The authors thank the patients, doctors and staff of CSPSs of Ouagadougou. Also, we thank the laboratory staff of Centre Muraz. The authors would also like to thank the staff of Action-Gouvernance-Integration-Renforcement (AGIR), the health authorities of Ouagadougou and Burkina Faso, and particularly the Ministry of Health, for their support in the study execution. Lastly, we would like to thank the Dengue Vaccine Initiative (DVI) team and statisticians and administrative staff at the International Vaccine Institute for their helpful comments during the preparation of this manuscript and support during the studies.